» Articles » PMID: 32155175

Epidemiological Survey of Serum Titers from Adults Against Various Gram-negative Bacterial V-antigens

Overview
Journal PLoS One
Date 2020 Mar 11
PMID 32155175
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The V-antigen, a virulence-associated protein, was first identified in Yersinia pestis more than half a century ago. Since then, other V-antigen homologs and orthologs have been discovered and are now considered as critical molecules for the toxic effects mediated by the type III secretion system during infections caused by various pathogenic Gram-negative bacteria. After purifying recombinant V-antigen proteins, including PcrV from Pseudomonas aeruginosa, LcrV from Yersinia, LssV from Photorhabdus luminescens, AcrV from Aeromonas salmonicida, and VcrV from Vibrio parahaemolyticus, we developed an enzyme-linked immunoabsorbent assay to measure titers against each V-antigen in sera collected from 186 adult volunteers. Different titer-specific correlation levels were determined for the five V-antigens. The anti-LcrV and anti-AcrV titers shared the highest correlation with each other with a correlation coefficient of 0.84. The next highest correlation coefficient was between anti-AcrV and anti-VcrV titers at 0.79, while the lowest correlation was found between anti-LcrV and anti-VcrV titers, which were still higher than 0.7. Sera from mice immunized with one of the five recombinant V-antigens displayed cross-antigenicity with some of the other four V-antigens, supporting the results from the human sera. Thus, the serum anti-V-antigen titer measurement system may be used for epidemiological investigations of various pathogenic Gram-negative bacteria.

Citing Articles

Molecular Targets and Strategies for Inhibition of the Bacterial Type III Secretion System (T3SS); Inhibitors Directly Binding to T3SS Components.

Hotinger J, Pendergrass H, May A Biomolecules. 2021; 11(2).

PMID: 33669653 PMC: 7922566. DOI: 10.3390/biom11020316.


Antibodies Inhibiting the Type III Secretion System of Gram-Negative Pathogenic Bacteria.

Hotinger J, May A Antibodies (Basel). 2020; 9(3).

PMID: 32726928 PMC: 7551047. DOI: 10.3390/antib9030035.

References
1.
Juan H, Tang R, Wu T, Yu K . Isolation of Aeromonas hydrophila in children with diarrhea. J Microbiol Immunol Infect. 2000; 33(2):115-7. View

2.
LIU P . The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo. J Infect Dis. 1966; 116(4):481-9. DOI: 10.1093/infdis/116.4.481. View

3.
Sawa T, Ohara M, Kurahashi K, Twining S, Frank D, Doroques D . In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections. Infect Immun. 1998; 66(7):3242-9. PMC: 108338. DOI: 10.1128/IAI.66.7.3242-3249.1998. View

4.
Mueller C, Broz P, Cornelis G . The type III secretion system tip complex and translocon. Mol Microbiol. 2008; 68(5):1085-95. DOI: 10.1111/j.1365-2958.2008.06237.x. View

5.
Gazi A, Charova S, Panopoulos N, Kokkinidis M . Coiled-coils in type III secretion systems: structural flexibility, disorder and biological implications. Cell Microbiol. 2009; 11(5):719-29. DOI: 10.1111/j.1462-5822.2009.01297.x. View